Aleniglipron looks like a credible oral alternative to injectable GLP-1 drugs, with comparable weight loss to existing options
This is expected given that weight change has a marked effect on the circulating proteome and durable increases in postprandial GLP-1 levels are thought to favorably contribute to both weight and metabolic outcomes after GBS 55
As a result of this, the PCDS and the Association of British Clinical Diabetologists have updated their joint guidance to assist healthcare professionals to overcome this particular challenge in the management of type 2 diabetes in adults
If youre unsure about what to do, consult your healthcare provider or pharmacist for guidance
A compounded prescription will read "semaglutide 2.5 mg/0.5 mL subcutaneous injection" or "tirzepatide 5 mg/0.5 mL subcutaneous injection," never "Ozempic" or "Wegovy." The legal framework: under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies may prepare patient-specific prescriptions for medications that are in shortage or medically necessary in a form not commercially available